.
|
Nanomaterials
|
||
 the Nanotech division of AMCOL International
|
produces nanocomposite clays for supply to the worldwide plastics industry since 1998. The inclusion of nano-oxides, nanopowders or nanocrystals helps improve dispersion and reduces abrasion in a wide variety of present day applications in paints, polishes, waxes, creams and lotions
|
|
|
engaged in the manufacture and engineering of nanocrystalline materials.
The Company’s products include, among others,
coated materials as ingredients for sunscreens, Nanophase’s largest application
uncoated materials as ingredients for personal care applications, including anti-fungal aids, automotive catalytic converters and abrasion-resistant flooring.
A growing new product area for Nanophase is the production of engineered nanomaterials, and their dispersion in a variety of media, for various electronics polishing applications.
|
||
|
Nanobiotechnology
|
||
|
The Company’s lead product candidate, Estrasorb, is a transdermal lotion for estrogen replacement therapy for which a New Drug Application (NDA) has been accepted for filing by the United States Food and Drug Administration (FDA). The NDA for Estrasorb was submitted in June 2001, and was accepted for filing in August 2001. Novavax is seeking FDA approval of Estrasorb for the reduction of hot flashes in menopausal women.
|
||
|
Nanoelectronics
|
||
|
|
|
|
Investment Companies & Indexes
|
||
|
A Company investing in Nanotech companies
|
||
|
Merrill Lynch’s Nanotech Index
|
||
